Local 12: Chemotherapy in recurrent ovarian cancer patients
UC researcher publishes New England Journal of Medicine study looking at outcomes
The five-year survival rate for ovarian cancer is only 36%, one of the worst cancer survival rates out there.
Finding the right treatments, however, is critical to changing that survival rate, according to Dr. Thomas Herzog, a professor at UC and gynecologic oncologist with UC Health. His team just released a study in the New England Journal of Medicine comparing those who just had chemotherapy with a recurrent cancer and those who had chemotherapy in addition to surgery when the cancer came back.
Featured photo courtesy of Unsplash.
Related Stories
Is there anything to fear from Hantavirus?
May 12, 2026
The University of Cincinnati's Carl Fichtenbaum, MD, professor of clinical medicine in the Division of Infectious Diseases in the Department of Internal Medicine at the College of Medicine, recently appeared on Scott Sloan's show on 700 WLW to share facts surrounding Hantavirus.
College of Medicine alumnae and faculty chair support shared alma mater
May 12, 2026
Michael A. Thomas, MD,[MS1.1] and Cincinnati OB-GYN Megan Kessler, MD, Med ’92 met in the hallways of the University of Cincinnati College of Medicine in the early 1990s.
From the pitch to personal impact
May 11, 2026
Hoxworth Blood Center, University of Cincinnati, is uniting blood donors around one shared mission — saving lives close to home — through two unique blood drives this May. From the FC Cincinnati Blood Drive at TQL Stadium to an event honoring local blood recipient and cancer survivor John Mattingly, these blood drives offer meaningful ways to give back. Whether inspired by hometown pride or a powerful personal story, blood donors are encouraged to roll up their sleeves and help ensure life-saving blood is available for patients across the Tristate. Patients at local hospitals depend on blood donations every day, and community support is critical to maintaining a strong supply.